Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Lung Cancer. 2014 Jul 27;86(1):14–21. doi: 10.1016/j.lungcan.2014.07.014

Table 3.

Multivariable Cox proportional hazard models for each time-period and for the entire cohort3

1986 to 1999
(N = 397)1
2000 to 2008
(N = 560)1
1986 to 2008
(N = 957)2
Characteristic HR (95% CI) HR (95% CI) HR (95% CI)
Time-period
  2000 to 2008 -- -- 1.00 (referent)
  1986 to 1999 -- -- 1.29 (1.11 – 1.49)
Age, N (%)
  < 50 1.00 (referent) 1.00 (referent) 1.00 (referent)
  ≥ 50 to ≤ 59 1.16 (0.76 – 1.78) 0.98 (0.70 – 1.35) 1.04 (0.80 – 1.34)
  ≥ 60 to ≤ 69 1.86 (1.23 – 2.80) 1.06 (0.77 – 1.46) 1.33 (1.04 – 1.69)
  ≥ 70 2.32 (1.52 – 3.54) 1.29 (0.92 – 1.81) 1.63 (1.26 – 2.11)
Gender, N (%)
  Female 1.00 (referent) 1.00 (referent) 1.00 (referent)
  Male 1.30 (1.05 – 1.60) 1.41 (1.17 – 1.70) 1.33 (1.16 – 1.53)
Smoking status, N (%)
  Never and Former 1.00 (referent) 1.00 (referent) 1.00 (referent)
  Current 1.47 (1.18 – 1.84) 1.15 (0.95 – 1.39) 1.30 (1.12 – 1.50)
Diagnostic test
  Histology 1.00 (referent) 1.00 (referent) 1.00 (referent)
  Cytology 0.82 (0.59 – 1.13) 1.53 (1.19 – 1.98) 1.15 (0.94 – 1.40)
  Missing/unknown -- 2.76 (0.38 – 19.98) 2.35 (0.33 – 16.85)
Summary of first course treatment
  Radiation and chemotherapy only 1.00 (referent) 1.00 (referent) 1.00 (referent)
  Chemotherapy only 1.00 (0.78 – 1.29) 1.33 (1.06 – 1.69) 1.15 (0.97 – 1.37)
  Surgery ± chemotherapy ± radiation ±
  other
0.41 (0.26 – 0.64) 0.97 (0.74 – 1.29) 0.69 (0.55 – 0.88)
  Chemotherapy ± radiation ± other 1.48 (0.64 – 3.42) 0.83 (0.53 – 1.32) 0.83 (0.56 – 1.23)
  None 1.69 (0.96 – 2.94) 3.33 (2.19 – 5.07) 2.17 (1.57 – 3.00)
  Missing/unknown -- 0.15 (0.04 – 0.63) 0.17 (0.41 – 0.67)
Stage, N (%)
  Limited 1.00 (referent) 1.00 (referent) 1.00 (referent)
  Extensive 2.96 (2.28 – 3.84) 2.83 (2.25 – 3.55) 2.79 (2.35 – 3.30)
  Not classifiable 0.79 (0.41 – 1.52) 1.31 (0.89 – 1.94) 1.08 (0.78 – 1.49)

Abbreviations: HR, Hazard Ratio; CI, confidence interval

Bold HRs indicate a statistically significant result

1

Patients with unknown smoking status were excluded (N = 13 for 1986 to 1999 and n = 62 for 2000 to 2008)

2

Patients with unknown smoking status were excluded (N = 75)

3

Complete follow-up data were not available on all patients. Samples sizes are based on number of patients with available vital status and follow-up information.